Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 5, Issue 1
High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Research Article
High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute
Online download statistics by month:
Online download statistics by month: December 2019 to February 2024
Abstract
Full
Pdf
Dec 2019
2
2
0
Jan 2020
5
5
0
Feb 2020
19
19
3
Mar 2020
15
15
5
Apr 2020
17
17
2
May 2020
45
45
24
Jun 2020
18
18
2
Jul 2020
13
13
2
Aug 2020
6
6
3
Sep 2020
25
25
4
Oct 2020
28
28
4
Nov 2020
33
33
6
Dec 2020
16
16
3
Jan 2021
19
19
3
Feb 2021
28
28
4
Mar 2021
104
104
3
Apr 2021
19
19
7
May 2021
12
12
6
Jun 2021
6
6
1
Jul 2021
11
11
3
Aug 2021
13
12
2
Sep 2021
17
17
7
Oct 2021
16
16
4
Nov 2021
19
19
4
Dec 2021
19
19
3
Jan 2022
18
19
5
Feb 2022
17
17
6
Mar 2022
17
18
5
Apr 2022
25
26
5
May 2022
43
45
5
Jun 2022
38
39
3
Jul 2022
31
32
4
Aug 2022
28
28
5
Sep 2022
26
26
12
Oct 2022
26
26
3
Nov 2022
25
26
15
Dec 2022
22
22
2
Jan 2023
22
22
3
Feb 2023
57
57
6
Mar 2023
33
35
7
Apr 2023
18
19
4
May 2023
10
10
5
Jun 2023
20
20
2
Jul 2023
16
16
5
Aug 2023
22
22
8
Sep 2023
20
20
5
Oct 2023
38
38
8
Nov 2023
71
71
3
Dec 2023
228
228
8
Jan 2024
31
32
13
Feb 2024
25
25
8
Total
1452
1463
260
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?